Legro, Richard S.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 2,143

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 2,132

Polycystic ovary syndrome

Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,005

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,976

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 1,919

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women

Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,743

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,593

Polycystic ovary syndrome

Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,360

Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,325

Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome

Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine

Ovarian function and disordersReproductive Health and Technologies

Cited by 1,027

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome

Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 1,020

Polycystic ovary syndrome

Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 838

The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global who guidance

Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update

Ovarian function and disordersReproductive Health and Technologies

Cited by 705

Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 703

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome

Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences

Ovarian function and disordersSexual Differentiation and Disorders

Cited by 699

American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome–part 1

Goodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 623

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 622

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics

Ovarian function and disordersGenetic Associations and Epidemiology

Cited by 619

Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries

Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology

Ovarian function and disordersAdrenal Hormones and Disorders

Cited by 556

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 525

Polycystic ovary syndrome

Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 495

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications

Ovarian function and disordersGenetic Associations and Epidemiology

Cited by 478

Polycystic ovary syndrome and cardiovascular disease: a premature association?

Legro, R. S. (2003) · Endocrine Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 466

Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls

Legro, R. S., Castracane, V. D., & Kauffman, R. P. (2004) · Obstetrical & Gynecological Survey

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 453